Fig. 2.
Fig. 2. Effect of Myelopoietin (MPO) administration (200 μg/kg/d) on the bone marrow-derived concentration of GM-CFC, MK-CFC, E-BFU, and GEMM-CFC in 700 cGy total body60Co-γ-irradiated animals. / Clonogenic activity was observed before (baseline [BL]) and on days 7, 14, 21, 48, and 100 after TBI and administration of MPO (n = 4, 200 μg/kg/d, BID) or a control protein (n = 10, HSA or AS) as described in Methods. All animals were assayed at each time point. Clonogenic concentrations (per 105 MNC) are reported as mean values ± SEM. Baseline GEMM-CFC are detectable in low concentration. There is no significant differences between the baseline values of MPO and control-treated animals. Asterisk (*) denotes significantly different from BL (P < .05); Hdenotes significantly greater than control protein, time-matched controls (P < .05); ↓ denotes zero values; ND denotes not done.

Effect of Myelopoietin (MPO) administration (200 μg/kg/d) on the bone marrow-derived concentration of GM-CFC, MK-CFC, E-BFU, and GEMM-CFC in 700 cGy total body60Co-γ-irradiated animals.

Clonogenic activity was observed before (baseline [BL]) and on days 7, 14, 21, 48, and 100 after TBI and administration of MPO (n = 4, 200 μg/kg/d, BID) or a control protein (n = 10, HSA or AS) as described in Methods. All animals were assayed at each time point. Clonogenic concentrations (per 105 MNC) are reported as mean values ± SEM. Baseline GEMM-CFC are detectable in low concentration. There is no significant differences between the baseline values of MPO and control-treated animals. Asterisk (*) denotes significantly different from BL (P < .05); Hdenotes significantly greater than control protein, time-matched controls (P < .05); ↓ denotes zero values; ND denotes not done.

Close Modal

or Create an Account

Close Modal
Close Modal